Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29013287 | 0.84 | — | — | |
| Glycerin SCHEMBL10788232 | 0.80 | ALDH1A1 (0.47) | LMNAALDH1A1THRB | |
| Glycerin SCHEMBL4073831 | 0.73 | ALDH1A1 (0.39) | LMNAALDH1A1 | |
| Glycerin SCHEMBL5226146 | 0.71 | ALDH1A1 (0.54) | LMNAALDH1A1 | |
| Glycerin SCHEMBL11796240 | 0.70 | LMNA (0.47) | LMNAALDH1A1THRB | |
| Glycerin SCHEMBL31376059 | 0.69 | — | — | |
| Glycerin SCHEMBL2936531 | 0.67 | LMNA (0.50) | LMNAALDH1A1THRB | |
| Glycerin SCHEMBL286713 | 0.67 | LMNA (0.50) | LMNAALDH1A1THRB | |
| SCHEMBL2462465 | 0.67 | — | — | |
| Glycerin SCHEMBL10784450 | 0.67 | ALDH1A1 (0.43) | LMNAALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021095618-A1 | GLYCERIN-CONTAINING EMULSIFIED COSMETICS | 株式会社成和化成 | 2021-05-20 | — | — | WO | disclosed |
| EP-2847268-B1 | COMPOSITION FOR THE PRODUCTION OF HYDROPHILIC POLYSTYRENE | CLARIANT INT LTD (CH) | 2016-06-08 | — | — | EP | disclosed |
| EP-2662407-A1 | Composition for the production of hydrophilic polystyrene | Clariant International Ltd. (CH) | 2013-11-13 | — | — | EP | disclosed |
| US-8163939-B2 | Ascorbic acid derivative or salt thereof, production method thereof, and cosmetic | Seikwa Kasei Company, Limited (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20110059034-A1 | ASCORBIC ACID DERIVATIVE OR SALT THEREOF, PRODUCTION METHOD THEREOF, AND COSMETIC | SEIWA KASEI COMPANY, LIMITED (JP) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059034-A1 | ASCORBIC ACID DERIVATIVE OR SALT THEREOF, PRODUCTION METHOD THEREOF, AND COSMETIC | CYP2R1, CYP24A1, RARA | LMNA 1946/4885ALDH1A1 89/4885THRB 4368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.